Biogennix launches OsteoSPAN fiber matrix

IRVINE, California, October 24, 2023 / OrthoSpineNews / – Irvine-based Biogennix, an osteobiology company that develops, manufactures and distributes proprietary bone graft products used for bone fusion procedures, today announced the launch of its new OsteoSPAN fiber matrix.

OsteoSPAN Fiber Matrix consists of 100% demineralized cortical fibers and is designed for optimized handling, while providing verified osteoinductive potential and an osteoconductive scaffold that supports cellular bone formation and stimulates fusion. OsteoSPAN Fiber Matrix is ​​also processed to provide fast, consistent hydration and fluid retention while resisting irrigation.

The OsteoSPAN fiber matrix is ​​malleable and cohesive when hydrated with blood or bone marrow, and expands to conform to irregular bone voids. The product is available in volumes of 1cc, 2.5cc, 5cc and 10cc.

“OsteoSPAN Fiber Matrix is ​​Biogennix’s first allograft product,” said Mark Borden, CTO of Biogennix. “We are excited to expand our portfolio with allografts that will complement our extensive synthetic offering and give us access to a new segment of the bone graft market.”

###

Biogennix^® is a fully integrated osteobiology company headquartered in Irvine that develops, manufactures and distributes proprietary bone graft products used in bone fusion procedures. Biogennix is ​​committed to advancing the technology behind natural bone grafting solutions, delivering outstanding quality with exceptional value and customer-focused excellence. More information can be found at biogennix.com.

Media contact:
Paul Williams
310-569-0023
paul@medialinecommunications.com